...was published in a 2015 Cell study and spun out into DayTwo Ltd. the same year. DayTwo...

...DISEASE CATEGORY: Neurology INDICATION: Amyotrophic lateral sclerosis (ALS) Co-founders and collaborators of DayTwo Ltd. and BiomX Ltd...

...Eran Elinav, who co-led the study, are Weizmann professors and co-founders of microbiome-based nutrition company DayTwo Ltd....

...$65 Million Series B to Target monoPARPs" ). Linking the gut microbiome with ALS symptoms DayTwo Ltd....
...polymerase; TYK2 - tyrosine kinase 2 Hongjiang Li and Sandi Wong, Staff Writers BMS-986165 BiomX Ltd. Bristol-Myers Squibb Co. Cytokinetics Inc. DayTwo Ltd. NanoString...

...Science Inc. (Tokyo, Japan); Neurimm Therapeutics (Paris, France), Siolta Therapeutics Inc. (San Francisco, Calif.); and DayTwo Ltd....

...immunology at Weizmann and a founder of microbiome companies BiomX Ltd. (Ness Ziona, Israel) and DayTwo Ltd....
...to aid a colony in engrafting to the gut (see "Bugs On Film" ). Mark Zipkin BiomX Ltd. DayTwo Ltd. Weizmann...

...examination of the microbiome's contribution. Segal and co-lead author Eran Elinav are scientific founders of DayTwo Ltd....

...The Janssen Human Microbiome Institute (JHMI) of Johnson & Johnson partnered with DayTwo and the Weizmann...
...N.J. DayTwo Ltd. , Tel Aviv, Israel Weizmann Institute of Science , Rehovot, Israel Business: Endocrine/Metabolic Alicia Parker DayTwo Ltd. Johnson...

...The pharma also announced a deal to develop a microbiome-based nutritional recommendation platform with DayTwo Ltd....
...diabetes and metabolic syndrome-associated disorders. The platform is based on research by Weizmann scientists and DayTwo...
...declined to provide additional terms of the deals. Jaime De Leon Caelus Health Johnson & Johnson Weizmann Institute of Science CP-001 DayTwo Ltd. DIA Disease...